Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Technology

Abstract

Purpose. The clinical efficacy of Chansu injection for COVID-19 treatment has been confirmed. Its mechanism of action remains unclear. We used network pharmacology and molecular docking technology to explore the potential material basis and mechanism of action of Chansu injection for COVID-19. Methods. The main components of Chansu injection were determined using HPLC. The PharmMapper, SwissTargetPrediction, SEA, and TCMID databases were used to screen for the active ingredients and therapeutic targets of Chansu injection, while the OMIM and GeneCards Suite databases were used to search for COVID-19-related targets. The STRING database was used for protein-protein interaction (PPI) network construction and topological analysis, while DAVID was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the core targets. The main active compounds of Chansu injection were docked with 3CL protease, ACE2, RdRp, and spike protein. Results. The three Chansu injection compounds were identified using HPLC. A total of 236 drug-related targets and 16,611 disease-related targets were identified, and 77 common targets were determined through mapping. The PPI mapping results revealed that 16 core targets were obtained through topological analysis and screening. Furthermore, GO and KEGG pathway enrichment analyses revealed that the PI3K and JAK-STAT signaling pathways are the major pathways. The molecular docking results suggest that the three Chansu injection components have high binding energies to the S protein. Conclusions. The potential mechanism of Chansu injection for COVID-19 involves multiple targets and pathways, thereby providing a scientific basis for its clinical application and further research.

Specnuezhenide ameliorates ultraviolet‐induced skin photoaging in mice by regulating the Sirtuin 3/8‐Oxoguanine DNA glycosylase signal

“…The study employed the SwissTargetPrediction database (http:// www.swiss targe tpred iction.ch/), PharmMapper database (http:// www.lilab -ecust.cn/pharm mappe r/), and SEA database (https:// sea.bkslab.org/), and integrated the target library of specnuezhenide. 15,16 Dermatitis-related disease targets were searched through the GeneCards database (https://www.genec ards.org) and OMIM database (https://www.omim.org/). 17 The target of specnuezhenide and the disease target were import into Venny2.1 (https:// bioin fogp.cnb.csic.es/tools/ venny/) to obtain the intersection.…”

The potential mechanism of Choulingdan mixture in improving acute lung injury based on HPLC–Q‐TOF–MS, network pharmacology and in vivo experiments

“…As indicated in Figure 2b, The protein-protein interaction (PPI) network was constructed, and its average degree value was 12.990. The target genes greater than twice the average degree value (≥26) were considered core targets (Xu et al, 2021), and 26 genes had parameters that met the above criteria, which might be the core targets for the treatment of ALI. Information on the 26 core targets is shown in Appendix 2.…”

Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies

“…The main active ingredients in CS included bufalin, resibufogenin, and cinobufagin, which possessed strong antiviral effects (Qi et al, 2018;Zhan et al, 2020). The result of molecular docking indicated that bufalin had the highest binding efficiency to 3CL protease, transcription factor AP-1 (ACE2), RNAdependent RNA polymerase (RdRp), and spike protein and potentially suggested that CS had a good therapeutic effect on COVID-19 (Xu et al, 2021). The top eight compounds in HSBD were quercetin, baicalein, kaempferol, beta-sitosterol, stigmasterol, isorhamnetin, naringenin, and formononetin.…”